Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131945) titled 'Venetoclax combined with cytarabine for consolidation therapy after induction in AML patients: A prospective, single-arm, multicenter, exploratory clinical study' on Sept. 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Acute myelogenous leukemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target Sample Size: Intervention group:77;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=336096...